ICD-10-CM 2027 diagnosis code
H30.129Disseminated chorioretinal inflammation, peripheral, unspecified eye
H30.129 is a valid, billable ICD-10-CM code for disseminated chorioretinal inflammation, peripheral, unspecified eye. It can be reported on claims for dates of service from October 1, 2026 – September 30, 2027.Short description: Disseminated chorioretin inflammation, peripheral, unsp eye
Code unchanged since ICD-10-CM took effect on October 1, 2015. Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data
About H30.129
H30.129 is the ICD-10-CM diagnosis code for disseminated chorioretinal inflammation, peripheral, unspecified eye. It belongs to category H30 (chorioretinal inflammation), block H30-H36 (disorders of choroid and retina) and chapter 7 (diseases of the eye and adnexa). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.
Within H30.12, choose H30.129 (unspecified eye) only when documentation doesn't support a more specific option: right eye (H30.121), left eye (H30.122) and bilateral (H30.123).
As a secondary diagnosis it is a CC (complication or comorbidity), which can move an inpatient stay into the "with CC" MS-DRG of its family, unless the principal diagnosis excludes it.
In MS-DRG v44.0, it is part of the grouping logic for DRG 124 (Other Disorders of the Eye with MCC or Thrombolytic Agent, relative weight 1.2471) and DRG 125 (Other Disorders of the Eye without MCC, relative weight 0.7702), in MDC 02 (Diseases and Disorders of the Eye), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.
It is an unspecified code for which a more specific option (often laterality) exists, and the Medicare Code Editor flags it for review on inpatient claims.
It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.
Before ICD-10, this condition was coded in ICD-9-CM as 363.12 (disseminated choroiditis and chorioretinitis, peripheral).
Notes that apply from higher levels
Instructions written at a parent level also apply to H30.129.
› From H30.1 Disseminated chorioretinal inflammation
- exudative retinopathy (H35.02-)
Broader instructions also apply from Chapter 7: Diseases of the eye and adnexa.
MS-DRG v44.0 grouping
All DRGs →Inpatient MS-DRGs this diagnosis can group to, as the principal or a secondary diagnosis, depending on the rest of the claim.
MDC 02 · Diseases and Disorders of the Eye
ICD-9-CM equivalent
Converter →- 363.12Disseminated choroiditis and chorioretinitis, peripheralapproximate
From the CMS 2018 General Equivalence Mappings (GEMs), the final GEMs release.
Code history
- 2016
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
- 2025
- 2026
- 2027
- FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
- No changes since FY2016.
Common questions about H30.129
Is H30.129 billable?
- Yes. H30.129 is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).
Can H30.129 be used as a principal diagnosis?
- Yes. The Medicare Code Editor doesn't restrict H30.129 as a principal diagnosis.
Is H30.129 a CC or MCC?
- H30.129 is a CC (complication or comorbidity) under MS-DRG v44.0, unless excluded by the principal diagnosis.
What DRG does H30.129 group to?
- H30.129 is used in the MS-DRG v44.0 logic for MS-DRG 124 (Other Disorders of the Eye with MCC or Thrombolytic Agent) and MS-DRG 125 (Other Disorders of the Eye without MCC). Which one applies depends on whether it is the principal diagnosis and on the rest of the claim.
What is the ICD-9 code for H30.129?
- The CMS General Equivalence Mappings map H30.129 to ICD-9-CM 363.12.